The pathogenesis of XLA is associated with a loss-of-function mutation in a single gene, Btk (Bruton’s tyrosine kinase), resulting in the arrest of B cell differentiation in the bone marrow at the pre-B cell stage. This evidence concerns the gene BTK and Bruton-type agammaglobulinemia.